Klaria Pharma Holding AB Asset Resilience Ratio

Latest as of December 2025: 0.84%

Klaria Pharma Holding AB asset resilience ratio. Klaria Pharma Holding AB (KLAR) has an Asset Resilience Ratio of 0.84% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See KLAR defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Skr342.00K

≈ $36.80K USD Cash + Short-term Investments

Total Assets

Skr40.77 Million

≈ $4.39 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Klaria Pharma Holding AB (2016–2025)

Asset resilience ratio of Klaria Pharma Holding AB from 2016 to 2025. This chart shows how Klaria Pharma Holding AB's Asset Resilience Ratio has changed over time. Read debt load of Klaria Pharma Holding AB for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Klaria Pharma Holding AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see KLAR total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr342.00K	0.84%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr342.00K	0.84%

Asset Resilience Insights

Limited Liquidity: Klaria Pharma Holding AB maintains only 0.84% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Klaria Pharma Holding AB Industry Peers by Asset Resilience Ratio

Compare Klaria Pharma Holding AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	11.84%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%
Jianmin Pharmaceutical Group Co Ltd SHG:600976	Drug Manufacturers - Specialty & Generic	20.61%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	Drug Manufacturers - Specialty & Generic	0.42%

Klaria Pharma Holding AB Asset Resilience Ratio by Year (2016–2025)

Klaria Pharma Holding AB asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Klaria Pharma Holding AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.84%	Skr342.00K ≈ $36.80K	Skr40.77 Million ≈ $4.39 Million	-0.21pp
2024-12-31	1.04%	Skr598.00K ≈ $64.35K	Skr57.27 Million ≈ $6.16 Million	-0.67pp
2023-12-31	1.71%	Skr1.25 Million ≈ $134.20K	Skr72.95 Million ≈ $7.85 Million	-12.23pp
2022-12-31	13.94%	Skr16.76 Million ≈ $1.80 Million	Skr120.27 Million ≈ $12.94 Million	-7.61pp
2021-12-31	21.55%	Skr25.49 Million ≈ $2.74 Million	Skr118.31 Million ≈ $12.73 Million	-2.06pp
2020-12-31	23.60%	Skr31.25 Million ≈ $3.36 Million	Skr132.41 Million ≈ $14.25 Million	+20.74pp
2019-12-31	2.87%	Skr2.92 Million ≈ $313.92K	Skr101.73 Million ≈ $10.95 Million	-4.62pp
2018-12-31	7.49%	Skr7.96 Million ≈ $856.52K	Skr106.25 Million ≈ $11.43 Million	-3.48pp
2017-12-31	10.97%	Skr17.10 Million ≈ $1.84 Million	Skr155.87 Million ≈ $16.77 Million	-8.22pp
2016-12-31	19.19%	Skr31.10 Million ≈ $3.35 Million	Skr162.03 Million ≈ $17.44 Million	--

pp = percentage points

About Klaria Pharma Holding AB

ST:KLAR Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$14.51 Million

Skr134.79 Million SEK

Market Cap Rank

#25937 Global

#529 in Sweden

Share Price

Skr0.55

Change (1 day)

+5.18%

52-Week Range

Skr0.46 - Skr1.22

All Time High

Skr17.00